NORDICCELL ApS: Financial statements 2022
CVR: 27293972
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 12,988,944 and a net result of DKK 4,223,740 compared with DKK 3,743,723 the year before. That is an increase of 19.9% compared with the year before. Equity in the 2022 report amounted to DKK 7,826,121. The solvency ratio was 56.4%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 12,988,944
- Profit/Loss
- DKK 4,223,740
- Equity
- DKK 7,826,121
- Total Assets
- DKK 13,877,094
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 13 mio. | 4.2 mio. | 7.8 mio. | 10 |
| 2021 | - | 10.8 mio. | 3.7 mio. | 7.3 mio. | 9 |
| 2020 | - | 8.6 mio. | 2.9 mio. | 4.3 mio. | 9 |
| 2019 | - | 6.8 mio. | 886 t. | 2.3 mio. | 10 |
| 2018 | - | 6.5 mio. | 1.5 mio. | 2.9 mio. | 10 |
Official annual report
Keep an eye on NORDICCELL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout NORDICCELL ApS
NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.